Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johannes W Smit

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Best Practice & Research. Clinical Endocrinology & Metabolism|August 24, 2022
Differentiated thyroid carcinoma: An updatePepijn van Houten, Romana T Netea-Maier, Johannes W Smit
European Journal of Internal Medicine|June 16, 2009
Long-term outcome of patients with macroprolactinomas initially treated with dopamine agonistsMarleen Kars, Alberto M Pereira, Johannes W Smit, et al.
Journal of Molecular Endocrinology|September 22, 2017
Pathological processes and therapeutic advances in radioiodide refractory thyroid cancerMarika H Tesselaar, Johannes W Smit, James Nagarajah, et al.
European Journal of Endocrinology|February 27, 2008
Combined immunostaining with galectin-3, fibronectin-1, CITED-1, Hector Battifora mesothelial-1, cytokeratin-19, peroxisome proliferator-activated receptor-{gamma}, and sodium/iodide symporter antibodies for the differential diagnosis of non-medullary thyroid carcinomaYing Y Liu, Hans Morreau, Job Kievit, et al.
Seminars in Immunology|May 12, 2018
Insights into the role of IL-32 in cancerYvette J E Sloot, Johannes W Smit, Leo A B Joosten, et al.
European Thyroid Journal|January 4, 2022
2022 ETA Consensus Statement: What are the indications for post-surgical radioiodine therapy in differentiated thyroid cancer?Furio Pacini, Dagmar Fuhrer, Rossella Elisei, et al.
Autophagy|July 30, 2015
Modulation of inflammation by autophagy: Consequences for human diseaseRomana T Netea-Maier, Theo S Plantinga, Frank L van de Veerdonk, et al.
The Journal of Clinical Endocrinology and Metabolism|November 3, 2005
Survival and death causes in differentiated thyroid carcinomaCarmen F A Eustatia-Rutten, Eleonora P M Corssmit, Nienke R Biermasz, et al.
European Journal of Endocrinology|July 17, 2008
Rituximab in relapsing Graves' disease, a phase II studyKaren A Heemstra, Rene E Toes, Jan Sepers, et al.
Endocrine-Related Cancer|April 22, 2017
Association of NF-κB polymorphisms with clinical outcome of non-medullary thyroid carcinomaTheo S Plantinga, Mirela S Petrulea, Marije Oosting, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Best Practice & Research. Clinical Endocrinology & Metabolism|August 24, 2022
Differentiated thyroid carcinoma: An updatePepijn van Houten, Romana T Netea-Maier, Johannes W Smit
European Journal of Internal Medicine|June 16, 2009
Long-term outcome of patients with macroprolactinomas initially treated with dopamine agonistsMarleen Kars, Alberto M Pereira, Johannes W Smit, et al.
Journal of Molecular Endocrinology|September 22, 2017
Pathological processes and therapeutic advances in radioiodide refractory thyroid cancerMarika H Tesselaar, Johannes W Smit, James Nagarajah, et al.
European Journal of Endocrinology|February 27, 2008
Combined immunostaining with galectin-3, fibronectin-1, CITED-1, Hector Battifora mesothelial-1, cytokeratin-19, peroxisome proliferator-activated receptor-{gamma}, and sodium/iodide symporter antibodies for the differential diagnosis of non-medullary thyroid carcinomaYing Y Liu, Hans Morreau, Job Kievit, et al.
Seminars in Immunology|May 12, 2018
Insights into the role of IL-32 in cancerYvette J E Sloot, Johannes W Smit, Leo A B Joosten, et al.
European Thyroid Journal|January 4, 2022
2022 ETA Consensus Statement: What are the indications for post-surgical radioiodine therapy in differentiated thyroid cancer?Furio Pacini, Dagmar Fuhrer, Rossella Elisei, et al.
Autophagy|July 30, 2015
Modulation of inflammation by autophagy: Consequences for human diseaseRomana T Netea-Maier, Theo S Plantinga, Frank L van de Veerdonk, et al.
The Journal of Clinical Endocrinology and Metabolism|November 3, 2005
Survival and death causes in differentiated thyroid carcinomaCarmen F A Eustatia-Rutten, Eleonora P M Corssmit, Nienke R Biermasz, et al.
European Journal of Endocrinology|July 17, 2008
Rituximab in relapsing Graves' disease, a phase II studyKaren A Heemstra, Rene E Toes, Jan Sepers, et al.
Endocrine-Related Cancer|April 22, 2017
Association of NF-κB polymorphisms with clinical outcome of non-medullary thyroid carcinomaTheo S Plantinga, Mirela S Petrulea, Marije Oosting, et al.
Pageof 4